z-logo
Premium
Does ongoing general practitioner care in elderly patients help reduce the risk of unplanned hospitalization related to B eers potentially inappropriate medications?
Author(s) -
Price Sylvie D,
Holman C D'Arcy J,
Sanfilippo Frank M,
Emery Jon D
Publication year - 2015
Publication title -
geriatrics and gerontology international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.823
H-Index - 57
eISSN - 1447-0594
pISSN - 1444-1586
DOI - 10.1111/ggi.12400
Subject(s) - medicine , polypharmacy , beers criteria , odds ratio , drug class , temazepam , emergency medicine , oxazepam , drug , benzodiazepine , psychiatry , receptor
Aim To compare estimates of unplanned hospitalizations associated with exposure to Beers potentially inappropriate medications ( PIM ) in elderly people receiving different levels of ongoing general practitioner ( GP ) care. Methods Using the pharmaceutical claims and other linked health data of 245 436 Western Australians aged ≥65 years with one or more claims for a medication from a PIM ‐related drug class (1993–2005), we applied an enhanced case–time–control design to obtain odds ratios ( OR ) for unplanned hospitalization, from which attributable fractions, numbers, proportions and rates of admissions related to PIM exposure were derived. Results Overall, 383 150 unplanned hospitalizations (“index subjects”) were identified. PIM exposure was associated with a similar relative risk of unplanned hospitalization in elderly people receiving the lowest and highest levels of ongoing GP care, but with a decreasing risk in the three highest tiers; adjusted OR (95% CI ; attributable fractions) were 1.15 (1.09–1.21; 12.9%), 1.36 (1.27–1.46; 26.6%), 1.20 (1.15–1.26; 16.9%) and 1.13 (1.09–1.17; 11.4%) for groups from the lowest to highest levels. However, those with higher GP coverage had higher rates of PIM ‐related hospitalization. Similar patterns were shown for commonly used high‐risk PIM (temazepam, diazepam, oxazepam, naproxen and digoxin). Conclusions Increased requirement for ongoing GP contact in less healthy elderly people appears to help minimize their risk of unplanned hospitalization due to PIM ‐related harm. GPs should continue to avoid B eers medications in older patients where possible, given their greater predisposition to medication exposure (including PIM ) and adverse drug events. Nevertheless, close monitoring of elderly patients who need to use PIM should prove beneficial. Geriatr Gerontol Int 2015; 15: 1031–1039.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here